Showing results (1-10 of 112) with videos related to
Sort By:
Pageof 12
The Journal of Biological Chemistry|July 8, 2000
Repression of BRCA1 through a feedback loop involving p53T K MacLachlan, B C Dash, D T Dicker, et al.Journal of Cellular Physiology|September 25, 1999
"p53: Twenty Years On" in Trieste, Italy, May 20-22, 1999T K Maclachlan, R D Meng, W S El-DeiryBiochemical and Biophysical Research Communications|November 2, 1999
Comparative gene expression profiling in response to p53 in a human lung cancer cell lineS Song, T K MacLachlan, R D Meng, et al.International Journal of Oncology|February 15, 2001
Enhanced TRAIL sensitivity by p53 overexpression in human cancer but not normal cell linesK Kim, R Takimoto, D T Dicker, et al.The Journal of Biological Chemistry|March 30, 2001
Death domain mutagenesis of KILLER/DR5 reveals residues critical for apoptotic signalingE R McDonald, P C Chui, P F Martelli, et al.Cancer Research|December 5, 2000
The caspase 9 inhibitor Z-LEHD-FMK protects human liver cells while permitting death of cancer cells exposed to tumor necrosis factor-related apoptosis-inducing ligandN Ozoren, K Kim, T F Burns, et al.The Journal of Biological Chemistry|January 25, 2000
BRCA1 effects on the cell cycle and the DNA damage response are linked to altered gene expressionT K MacLachlan, K Somasundaram, M Sgagias, et al.Current Opinion in Oncology|January 1, 1997
Role of oncogenes in resistance and killing by cancer therapeutic agentsW S el-DeiryCell Death and Differentiation|November 1, 2001
Insights into cancer therapeutic design based on p53 and TRAIL receptor signalingW S El-DeiryPageof 12